Andere talen NEOS AB

Aandelen

NEOD

SE0021615655

Beurs gesloten - Nasdaq Stockholm Andere beurzen 14:32:06 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,908 ^SEK	-0,22%		-9,20%	-58,73%

22/03	NeoDynamics AB (publ) kondigt wijzigingen aan in Chief Executive Officer	CI
29/02	Anna Eriksrud kondigt aan met pensioen te willen gaan als CEO van NeoDynamics AB (publ)	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NeoDynamics AB Announces Appointment of Matilda Salén as Its New Chief Executive Officer	22/03
Anna Eriksrud Announces Desire to Retire as CEO of NeoDynamics AB	29/02
NeoDynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
NeoDynamics AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02
Neodynamics Launches Device Registry in Germany, Cost-Effective Collection of Real-World Data	11/12
NeoDynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
NeoDynamics Announces Cost Reduction Plan	13/11
NeoDynamics AB Receives New Order from Western Rhineland-Palatinate Hospital in Germany	18-10-23
NeoDynamics Soars 42% Amid First US Order for Invasive Biopsy System NeoNavia	09-08-23
NeoDynamics AB Receives First Commercial Order from Top University Hospital	09-08-23
NeoDynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31-07-23
Neodynamics AB Presents Results of Pulse Study At the Annual Congress of the German Society of Senology, Munich	10-07-23
NeoDynamics Plans SEK72 Million Rights Issue to Fund Commercialization, Marketing Operations	23-06-23
NeoDynamics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	11-05-23
NeoDynamics AB Presents Final Data Set from NeoDynamics' Pulse Study Presented at the SBI Breast Imaging Symposium	05-05-23
Sweden’s NeoDynamics Launches New Biopsy Technology in US	27-04-23
Neodynamics, Inc. Announces U.S. Availability of Neonavia, the First and Only Pulse Biopsy Technology, Fda-Cleared in Breast and Axillary Lymph Node Biopsies	27-04-23
Neodynamics AB Announces Delivery of Corepulse Needles to 23 Hospitals	03-04-23
NeoDynamics Receives Chinese Patent for NeoNavia FlexiPulse	06-03-23
NeoDynamics AB Receives Chinese Patent for FlexiPulse Needle Design	06-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NEOS AB

Aandelen

NEOD

SE0021615655

Andere talen

Filters